Jun 2
|
Cytek Biosciences Leads Our Top 3 Penny Stock Selections
|
May 30
|
Cytek Biosciences, Inc. (CTKB) Elevates Cell Analysis with New Aurora Evo System
|
May 29
|
Cytek® Biosciences Is Setting the New Standard for Full Spectrum Flow Cytometry with the New Cytek Aurora™ Evo Flow Cytometer
|
May 28
|
Cytek Biosciences to participate at the Goldman Sachs 46th Annual Global Healthcare Conference
|
Apr 24
|
Cytek Biosciences to Report First Quarter 2025 Financial Results on May 8, 2025
|
Apr 16
|
April 2025's Top Penny Stocks To Watch
|
Mar 10
|
Open Lending Leads Our Trio Of Promising Penny Stocks
|
Mar 1
|
Is There An Opportunity With Cytek Biosciences, Inc.'s (NASDAQ:CTKB) 22% Undervaluation?
|
Feb 28
|
Cytek Biosciences Inc (CTKB) Q4 2024 Earnings Call Highlights: Strong International Growth and ...
|
Feb 27
|
Cytek Biosciences, Inc. (CTKB) Tops Q4 Earnings Estimates
|
Feb 27
|
Cytek Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Provides 2025 Outlook
|
Jan 15
|
Cytek Biosciences Announces Preliminary Full Year 2024 Revenue Results
|
Jan 2
|
Cytek Biosciences to present at the 43rd Annual J.P. Morgan Healthcare Conference
|
Dec 30
|
Cytek Biosciences Announces $50 Million Stock Repurchase Program for 2025
|
Aug 8
|
Cytek Biosciences to Participate in Upcoming Investor Conferences
|
Aug 8
|
Cytek Biosciences Second Quarter 2024 Earnings: Misses Expectations
|
Aug 6
|
Cytek Biosciences, Inc. (CTKB) Reports Q2 Loss, Lags Revenue Estimates
|
Aug 6
|
Cytek Biosciences Reports Second Quarter 2024 Financial Results
|
Jul 30
|
Cytek® Biosciences Automates Panel Design with New Intelligent Algorithm
|
Jul 30
|
Cytek Biosciences to Report Second Quarter 2024 Financial Results on August 6, 2024
|